Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Simcere Pharmaceutical Group (2096 HK)
Watchlist
53
Analysis
Health Care
•
China
Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company's products include antibiotics, anti-cancer medications and anti-stroke medications.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Quantitative Analysis
•
06 Nov 2022 14:12
Hong Kong Connect Flows (Nov 4th): Tencent, Meituan, Wuxi Biologics, Li Ning
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent, Meituan, Wuxi Biologics, Li Ning.
Ke Yan, CFA, FRM
Follow
235 Views
Share
bearish
•
CanSino Biologics
•
03 Nov 2022 10:35
CanSino Biologics (6185.HK/688185.CH) - Time to Offload; the Rally May Not Last Long
The fake news about China reopen and COVID-19 vaccine business are major driving force for the rally of CanSino’s share price, but such rally would...
Xinyao (Criss) Wang
Follow
183 Views
Share
bullish
•
Thematic (Sector/Industry)
•
02 Oct 2022 09:23
China Healthcare Weekly (Sep.30) - Orthopedics VBP, CGT CDMO, Surgical Robots, Bottom of HKEX
Orthopedics VBP result was released,we analyzed the impact on companies; There will be few real clinical needs for surgical robots; There're hidden...
Xinyao (Criss) Wang
Follow
283 Views
Share
bearish
•
Genuine Biotech
•
17 Sep 2022 23:21
Genuine Biotech (GBL HK): COVID Pill No Longer Attractive Opportunity; Thin Pipeline Mars Conviction
Genuine Biotech has filed for Hong Kong listing to raise funds to commercialize its newly approved drug. The company’s Azvudine is the first China...
Tina Banerjee
Follow
322 Views
Share
bearish
•
Simcere Pharmaceutical Group
•
13 Sep 2022 08:57
Simcere Pharmaceutical Group (2096.HK) 22H1 - Gloomy Outlook and Risks in Profits
Simcere’s profit was driven by investment business, which will further decline due to unfriendly macro. The pipeline quality is not high, leading...
Xinyao (Criss) Wang
Follow
227 Views
Share
First
Previous
2
3
4
5
6
7
8
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.1
x